PA
Paragon Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
6,447
+78
| +1% | +$60.8K | 1.31% | 18 |
|
|
2025
Q1 | $5.26M | Sell |
6,369
-18
| -0.3% | -$14.9K | 1.99% | 12 |
|
|
2024
Q4 | $4.93M | Sell |
6,387
-136
| -2% | -$105K | 1.69% | 18 |
|
|
2024
Q3 | $5.78M | Buy |
6,523
+28
| +0.4% | +$24.8K | 1.88% | 11 |
|
|
2024
Q2 | $5.88M | Buy |
6,495
+2,933
| +82% | +$2.66M | 2.14% | 11 |
|
|
2024
Q1 | $2.77M | Buy |
3,562
+1,332
| +60% | +$1.04M | 1.12% | 27 |
|
|
2023
Q4 | $1.3M | Buy |
2,230
+511
| +30% | +$298K | 0.55% | 54 |
|
|
2023
Q3 | $923K | Buy |
1,719
+133
| +8% | +$71.4K | 0.38% | 65 |
|
|
2023
Q2 | $743K | Sell |
1,586
-2,410
| -60% | -$1.13M | 0.24% | 83 |
|
|
2023
Q1 | $1.37M | Buy |
3,996
+1,413
| +55% | +$485K | 0.46% | 54 |
|
|
2022
Q4 | $944K | Buy |
+2,583
| New | +$944K | 0.42% | 55 |
|